Loading clinical trials...
Loading clinical trials...
Randomized Multicenter Double-Masked Placebo-Controlled Parallel Phase I/II Study to Determine the Safety and Exploratory Efficacy of Topical Fibrinogen Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs Host Disease
Conditions
Interventions
CAM-101 10%
Vehicle Control
+1 more
Locations
6
United States
Byers Eye Institute of Stanford University
Palo Alto, California, United States
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, United States
University of Michigan - Kellogg Clinical Research Center
Ann Arbor, Michigan, United States
University of Minnesota
Minneapolis, Minnesota, United States
Duke University Eye Center
Durham, North Carolina, United States
Oregon Health Sciences University - Casey Eye Institute
Portland, Oregon, United States
Start Date
May 1, 2018
Primary Completion Date
December 12, 2019
Completion Date
February 20, 2020
Last Updated
July 27, 2021
NCT07124078
NCT07463950
NCT07363824
NCT07396441
NCT07298811
NCT07295691
Lead Sponsor
Cambium Bio Limited
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions